TAVANIC i.v. sol perf 500 mg/100ml flac 100 ml
7680543660195
CH-54366
J01MA12
08.01.8.
Reimbursement limitations:
PARENTANW
Administration parentérale seulement pour patients qui ne peuvent pas prendre des médicaments par voie orale.
1 / 3
google
Details
- Product number
- 5436601
- CPT
- -
- Packaging group
- 1 x 100 ml
- Unit
- Flasche(n)
- Composition
- levofloxacinum 500 mg ut levofloxacinum hemihydricum, natrii chloridum, acidum hydrochloridum concentratum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 100 ml corresp. natrium 354 - 371 mg.
Articles (1)
Tavanic i.v. 500, solution pour perfusion
Infusionslösung
1 x 100 ml
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 58.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1998
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 54366
- Drug name
- Tavanic i.v., solution pour perfusion
- Galenic form
- LSINF
- ATC Code
- J01MA12
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/02/1998
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.8.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TAVANIC i.v. sol perf 500 mg/100ml flac 100 ml
- Description (DE)
- TAVANIC i.v. Inf Lös 500 mg/100ml Durchstf 100 ml
- Market launch
- 26/02/1998
- Narcotic (BTM)
- No